The 3rd Opinion

Rather than launching another disease awareness campaign, the Third Opinion campaign addressed the behavioural gap at the exact moment that matters: the treatment consultation. Looking at a patient’s journey, we discovered people get first opinions (diagnosis) and seek second opinions (specialist validation) but rarely recognise their own perspective as equally valid. In everyday situations, people instinctively voice their preferences when ordering food, planning holidays, or talking about films. Yet despite 69% of doctors encouraging them to speak up, when diagnosed with lung cancer, that confidence disappears. By repositioning the patient's voice as the essential "3rd Opinion," we coined a new term and ownable framework that empowers patients while supporting physicians who value shared decision-making but lack practical tools to facilitate it. This campaign transcends typical pharmaceutical communications by creating genuine behavioural change at the patient-physician interface. By establishing “The 3rd Opinion" as an ownable framework for shared decision-making, we've contributed a lasting tool to healthcare conversations across APAC. The incredible success of social media activation in Taiwan and Southeast Asia isn't based on vanity metrics; it represents thousands of patients newly empowered to voice their treatment priorities. The campaign was validated by 20 leading advocates representing 17 Patient Association Groups who wholeheartedly endorsed The 3rd Opinion. The campaign demonstrates PR excellence through authentic storytelling, strategic multi-stakeholder engagement, exceptional execution efficiency, and measurable impact on health behaviours, the ultimate goal of healthcare communications.